# Acadia Pharmaceuticals Inc: Form 8-K, filed Nov 21, 2023

- Company: [Acadia Pharmaceuticals Inc](/companies/acad.md) (CIK 1070494)
- Form: 8-K
- Filed: 2023-11-21
- Accepted by EDGAR: Nov 21, 2023, 17:11 ET
- Period: 2023-11-21
- Accession: 0001193125-23-281574
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070494/000119312523281574/d586090d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070494/000119312523281574/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070494/000119312523281574/d586090d8k.htm

Filed Nov 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-281574. Last ingested by Listed: Nov 10, 2026, 16:33 ET. No prices; not investment advice.